These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2522312)

  • 21. Expert witnesses and experimental treatment: the extent of the duty to warn of risks when using experimental treatment.
    Brahams D
    Med Leg J; 2001; 69(Pt 1):35-6. PubMed ID: 11388068
    [No Abstract]   [Full Text] [Related]  

  • 22. [Occupational vitiligo].
    Arievich AM; Selisskiĭ GD
    Vestn Dermatol Venerol; 1980 May; (5):46-9. PubMed ID: 6446213
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of occupational hazards in healthcare: exposure to diphencyprone.
    Basu S; Adisesh A
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23417940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [What's new in American dermatology?].
    Hollander A
    Hautarzt; 1973 Jun; 24(6):225-9. PubMed ID: 4364401
    [No Abstract]   [Full Text] [Related]  

  • 25. Pseudoallergic reaction from Khellin in photochemotherapy of vitiligo: a case report.
    Jung EG; Fingerhut W
    Photodermatol; 1988 Oct; 5(5):235-6. PubMed ID: 2975780
    [No Abstract]   [Full Text] [Related]  

  • 26. Alopecia areata: topical immunotherapy treatment with diphencyprone.
    Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contact vitiligo following a strong patch test reaction to triglycidyl-p-aminophenol in an aircraft industry worker: case report and review of the literature.
    Jappe U; Geier J; Hausen BM
    Contact Dermatitis; 2005 Aug; 53(2):89-92. PubMed ID: 16033402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin.
    Abdel Naser MB; Wollina U; El Okby M; El Shiemy S
    Clin Exp Dermatol; 2004 Jul; 29(4):380-2. PubMed ID: 15245535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hazards in the use of diphencyprone.
    Adisesh A; Beck M; Cherry NM
    Br J Dermatol; 1997 Mar; 136(3):470. PubMed ID: 9115942
    [No Abstract]   [Full Text] [Related]  

  • 30. [Flutamide and pseudoporphyria].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 1999 Apr; 126(4):374. PubMed ID: 10421946
    [No Abstract]   [Full Text] [Related]  

  • 31. [The use of Xalacom and deterioration in cases of vitiligo. Is there a causal relationship?].
    Arnalich-Montien F; Lara-Medina J; Muñoz-Negrete FJ; Rebolleda G
    Arch Soc Esp Oftalmol; 2004 Jul; 79(7):315-6. PubMed ID: 15286899
    [No Abstract]   [Full Text] [Related]  

  • 32. [Skin and systemic disease caused by occupational contact with p-tert-butylphenol. Case reports].
    Budde J; Stary A
    Derm Beruf Umwelt; 1988; 36(1):17-9. PubMed ID: 2966731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occupational vitiligo due to unsuspected presence of phenolic antioxidant byproducts in commercial bulk rubber.
    O'Malley MA; Mathias CG; Priddy M; Molina D; Grote AA; Halperin WE
    J Occup Med; 1988 Jun; 30(6):512-6. PubMed ID: 2969045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Generalized allergic dermatitis following xyline anesthesia].
    Puchiţă M; Cuibuş E
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Stomatol; 1985; 32(2):155-8. PubMed ID: 2933771
    [No Abstract]   [Full Text] [Related]  

  • 35. Vitiligo as an occupational disease.
    Swarbrick P
    Occup Health (Lond); 1980 Sep; 32(9):442-8. PubMed ID: 6448968
    [No Abstract]   [Full Text] [Related]  

  • 36. [Melanoleukoderma following treatment with hydroquinone monobenzylether].
    Balabanow K; Durmischev AL; Tschernozemsky I
    Asthet Med (Berl); 1968 Oct; 17(10):233-4. PubMed ID: 5306153
    [No Abstract]   [Full Text] [Related]  

  • 37. [Is the coincidence of vitiligo and professional exposure to parateriary butylphenol in polychloroprene glues a causality or not? (author's transl)].
    Richter G; Wozel G
    Dermatol Monatsschr; 1980 Jul; 166(7):489-95. PubMed ID: 6448756
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of alopecia areata of the eyebrow with diphenylcyclopropenone and its possible risks].
    Lutz G; Kreysel HW
    Z Hautkr; 1989 Oct; 64(10):898-900. PubMed ID: 2588751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: Occupational vitiligo caused by paratertiary butylphenol.
    Rodermund OE
    Arch Dermatol; 1976 Apr; 112(4):554-5. PubMed ID: 131517
    [No Abstract]   [Full Text] [Related]  

  • 40. Vitiligo-like syndrome following the use of fluphenazine enanthate.
    Rampertaap MP
    Mo Med; 1985 Jan; 82(1):24-6. PubMed ID: 3969064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.